| Administration of Fingolimod in Greek Patients With Multiple Sclerosis. (NCT06949956) | Elpen Pharmaceutical Co. Inc. | 2025-06-01 |
| Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/Tamsulosin. (NCT06528613) | Elpen Pharmaceutical Co. Inc. | 2024-10-23 |
| TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone. (NCT06117722) | Elpen Pharmaceutical Co. Inc. | 2024-03-06 |
| QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt. (NCT06170125) | Elpen Pharmaceutical Co. Inc. | 2024-03-01 |
| Clinical Study for the Effectiveness of Roflumilast Treatment in COPD Greek Patients Based on Standard Clinical Practice. (NCT05426915) | Elpen Pharmaceutical Co. Inc. | 2023-05-01 |
| Adherence of Iron Succinylate Therapy in Pregnancy (NCT03873571) | Elpen Pharmaceutical Co. Inc. | 2022-12-30 |
| Ezetimibe-Rosuvastatin Evaluation Study (NCT03947866) | Elpen Pharmaceutical Co. Inc. | 2022-09-30 |
| Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy (NCT03873584) | Elpen Pharmaceutical Co. Inc. | 2022-09-01 |
| Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease. (NCT05168215) | Elpen Pharmaceutical Co. Inc. | 2022-01-01 |
| Clinical Effectiveness of PAPILOCARE® in Regression of Cervix HPV Cytological Abnormalities (PAPILOBS GR). (NCT06399341) | Elpen Pharmaceutical Co. Inc. | 2021-09-01 |
| Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II) (NCT04831476) | Elpen Pharmaceutical Co. Inc. | 2021-09-01 |
| AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to Standard Clinical Practice. (NCT04835961) | Elpen Pharmaceutical Co. Inc. | 2021-05-01 |
| Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure (NCT03947853) | Elpen Pharmaceutical Co. Inc. | 2019-10-01 |
| A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination (NCT03858348) | Elpen Pharmaceutical Co. Inc. | 2019-05-01 |
| Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation (NCT03162120) | Elpen Pharmaceutical Co. Inc. | 2018-09-01 |
| Prospective Study of the Evaluation of Disease contRol and the Quality of Life of Patients With depressiOn and With or Without aNxiety disOrders in the Greek populatIon (NCT03317262) | Elpen Pharmaceutical Co. Inc. | 2018-03-01 |
| PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENT (NCT03329729) | Elpen Pharmaceutical Co. Inc. | 2018-02-01 |
| COMPLliancE and qualiTy of lifE in Asthma (NCT03300076) | Elpen Pharmaceutical Co. Inc. | 2018-02-01 |
| COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF (NCT02582190) | Elpen Pharmaceutical Co. Inc. | 2017-12-02 |
| AdHerencE to Treatment and quAlity of Life in COPD (NCT03299673) | Elpen Pharmaceutical Co. Inc. | 2017-12-01 |
| Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial Hypertension (NCT03139084) | Elpen Pharmaceutical Co. Inc. | 2017-12-01 |